Cargando…

Azithromycin in the extremely low birth weight infant for the prevention of Bronchopulmonary Dysplasia: a pilot study

BACKGROUND: Azithromycin reduces the severity of illness in patients with inflammatory lung disease such as cystic fibrosis and diffuse panbronchiolitis. Bronchopulmonary dysplasia (BPD) is a pulmonary disorder which causes significant morbidity and mortality in premature infants. BPD is pathologica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ballard, Hubert O, Anstead, Michael I, Shook, Lori A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1896160/ https://www.ncbi.nlm.nih.gov/pubmed/17550598 http://dx.doi.org/10.1186/1465-9921-8-41

Ejemplares similares

Pulmonary function in extremely low birth weight infants with bronchopulmonary dysplasia before hospital discharge
por: McEvoy, Cindy T., et al.
Publicado: (2020)

Vitamin A to prevent bronchopulmonary dysplasia in extremely low birth weight infants: a systematic review and meta-analysis
por: Araki, Shunsuke, et al.
Publicado: (2018)

Mesenchymal stem cell bioenergetics and apoptosis are associated with risk for bronchopulmonary dysplasia in extremely low birth weight infants
por: Hazra, Snehashis, et al.
Publicado: (2022)

Improved weight attainment of extremely low-gestational-age infants with bronchopulmonary dysplasia
por: Madden, J, et al.
Publicado: (2010)

Serum Eotaxin-1 is Increased in Extremely Low Birth Infants with Bronchopulmonary Dysplasia or Death
por: Kandasamy, Jegen, et al.
Publicado: (2015)

High Incidence of Rickets in Extremely Low Birth Weight Infants with Severe Parenteral Nutrition-Associated Cholestasis and Bronchopulmonary Dysplasia
por: Lee, Soon Min, et al.
Publicado: (2012)

Myocardial Function Maturation in Very-Low-Birth-Weight Infants and Development of Bronchopulmonary Dysplasia
por: Méndez-Abad, Paula, et al.
Publicado: (2020)

Influence of early fluid overload on bronchopulmonary dysplasia in very low-birth-weight infants
por: Li, Yu-Jie, et al.
Publicado: (2022)

The value of hematocrit for predicting bronchopulmonary dysplasia in very low birth weight preterm infants
por: Wang, Xuesong, et al.
Publicado: (2023)

Vascular Endothelial Growth Factor as Molecular Target for Bronchopulmonary Dysplasia Prevention in Very Low Birth Weight Infants
por: Perrone, Serafina, et al.
Publicado: (2023)

Trends in survival among extremely-low-birth-weight infants (less than 1000 g) without significant bronchopulmonary dysplasia
por: Botet, Francesc, et al.
Publicado: (2012)

Predictors of Bronchopulmonary Dysplasia in Infants With Birth Weight Less Than 1500 g
por: Maytasari, Galuh Martin, et al.
Publicado: (2023)

Recent Changes in the Incidence of Bronchopulmonary Dysplasia among Very-Low-Birth-Weight Infants in Korea
por: Jo, Heui Seung, et al.
Publicado: (2015)

Dose-dependent effect of human milk on Bronchopulmonary dysplasia in very low birth weight infants
por: Xu, Yan, et al.
Publicado: (2020)

Development and Validation of a Nomogram for Predicting Bronchopulmonary Dysplasia in Very-Low-Birth-Weight Infants
por: Zhang, Jingdi, et al.
Publicado: (2021)

Late-Onset Sepsis as a Risk Factor for Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants: A Nationwide Cohort Study
por: Jung, Euiseok, et al.
Publicado: (2019)

Airway nitrite is increased in extremely preterm infants with bronchopulmonary dysplasia
por: Gentle, Samuel J., et al.
Publicado: (2020)

Neonatal ibuprofen exposure and bronchopulmonary dysplasia in extremely premature infants
por: Chen, Xueyu, et al.
Publicado: (2019)

Development and verification of a risk prediction model for bronchopulmonary dysplasia in very low birth weight infants
por: Cai, Huiwen, et al.
Publicado: (2021)

Can red cell distribution width in very low birth weight infants predict bronchopulmonary dysplasia?
por: Oh, Seong Hee, et al.
Publicado: (2022)

Utility of umbilical cord blood 25-hydroxyvitamin D levels for predicting bronchopulmonary dysplasia in preterm infants with very low and extremely low birth weight
por: Yu, Haoting, et al.
Publicado: (2022)

Risk factors and clinical characteristics for bronchopulmonary dysplasia associated pulmonary hypertension in very-low-birth-weight infants
por: Sun, Junfang, et al.
Publicado: (2021)

Systematic review and meta-analysis: the effect of bronchopulmonary dysplasia on neurodevelopment in very low birth weight premature infants
por: Gao, Shuqiang, et al.
Publicado: (2021)

Molecular Polymorphisms of Vascular Endothelial Growth Factor Gene and Bronchopulmonary Dysplasia in Very Low Birth Weight Infants
por: Filonzi, Laura, et al.
Publicado: (2022)

Health Care Burden of Bronchopulmonary Dysplasia Among Extremely Preterm Infants
por: Mowitz, Meredith E., et al.
Publicado: (2019)

State of the Art Review: Delivery room interventions to prevent bronchopulmonary dysplasia in extremely preterm infants
por: Foglia, Elizabeth E., et al.
Publicado: (2017)

Bronchopulmonary dysplasia frequency and risk factors in very low birth weight infants: A 3-year retrospective study
por: Cokyaman, Turgay, et al.
Publicado: (2019)

The Prediction of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants through Clinical Indicators within 1 Hour of Delivery
por: Shim, So-Yeon, et al.
Publicado: (2021)

The Impact of Time Interval Between First Extubation and Reintubation on Bronchopulmonary Dysplasia or Death in Very Low Birth Weight Infants
por: Li, Jing, et al.
Publicado: (2022)

Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE)
por: McEvoy, Cindy T., et al.
Publicado: (2020)

Influence of time under mechanical ventilation on bronchopulmonary dysplasia severity in extremely preterm infants: a pilot study
por: Escobar, Victoria, et al.
Publicado: (2020)

Molecular Mechanism of Caffeine in Preventing Bronchopulmonary Dysplasia in Premature Infants
por: Tian, Congliang, et al.
Publicado: (2022)

Pulmonary hypertension in infants with bronchopulmonary dysplasia
por: Kim, Gi Beom
Publicado: (2010)

Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
por: Rivera, Lidys, et al.
Publicado: (2016)

Two-stage learning-based prediction of bronchopulmonary dysplasia in very low birth weight infants: a nationwide cohort study
por: Hwang, Jae Kyoon, et al.
Publicado: (2023)

Association of Ureaplasma infection pattern and azithromycin treatment effect with bronchopulmonary dysplasia in Ureaplasma positive infants: a cohort study
por: Chen, Xueyu, et al.
Publicado: (2023)

Systemic postnatal corticosteroid use for the prevention of bronchopulmonary dysplasia and its relationship to early neurodevelopment in extremely preterm infants
por: Esterman, Emilia, et al.
Publicado: (2023)

Bronchopulmonary dysplasia predicted at birth by artificial intelligence
por: Verder, Henrik, et al.
Publicado: (2020)

Infection prevention for extremely low birth weight infants in the NICU
por: Fleiss, Noa, et al.
Publicado: (2022)

Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants
por: Chen, Xueyu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dhrptps7q1529q1sbbluojs5u5